|
Dr. Diamond joined Magellan in August 2007 to help the company leverage its existing technologies and development capabilities across the company. His charge is to help define and implement Magellan’s diagnostic-product portfolio strategy providing scientific expertise and leadership to help ensure that its product pipeline is compelling, high quality, and delivered in a timely manner to meet market needs. His input is also critical in Magellan’s acquisition, licensing, and partnership strategy where he provides scientific evaluation and counsel in the company’s pursuit of complementary technologies that expand its presence in the point-of-care and hospital-laboratory segments.Dr. Diamond came to Magellan from Siemens Medical Solutions Diagnostics (formerly Bayer Diagnostics), where he was vice president, research and development, for the point-of-care product lines: urinalysis, blood gas, and HbA1c (diabetes testing). In addition to internal product development, Dr. Diamond had an active role in the evaluation and development of external technologies to enhance and extend the company’s products for near-patient testing. Under his stewardship, Bayer successfully developed and launched a suite of market-leading products for near-patient testing.Dr. Diamond previously held several senior-level positions at Bayer Diagnostics. From 2000-2004, he was vice president research and development for the near-patient-testing segment. Before that, he was vice president, research and development for the self-testing segment. Prior to joining Bayer, he was vice president, research and development for the Stratus Immunochemistry business of Baxter Diagnostics. Dr. Diamond received a bachelor’s degree cum laude in chemistry from Rensselaer Polytechnic Institute (Troy, New York) and a PhD in chemistry from Stanford University (Stanford, California), with Nobel Laureate, Professor Henry Taube, as his research advisor. He is the recipient of several honors and awards, has authored many technical publications and abstracts in peer-reviewed journals, and is the co-holder of numerous United States and international patents. | 